Interface Biologics raises $7 million
Closely held Interface Biologics of Toronto has completed a $7 million series B financing, led by Business Development Bank of Canada, in conjunction with Covington Capital and VG Partners. “Based on...
View ArticleIn conversation with Alistair Duncan
Alistair Duncan As a co-founder, president and CEO of closely held viDA Therapeutics, a tissue repair company, Alistair Duncan has developed an affinity for doing biotech startups. From 1998 to 2008,...
View Article
More Pages to Explore .....